Works matching IS 13520504 AND DT 2017 AND VI 24

Results: 181

Estimating HCV disease burden—volume 4 (editorial).

Published in:

2017

By:

Dore, G. J.;
Hatzakis, A.;
Negro, F.;
Waked, I.

Publication type:

Editorial

Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment-naïve, noncirrhotic HCV genotype 3-infected patients.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 895, doi. 10.1111/jvh.12719

By:

Gane, E.;
Nahass, R.;
Luketic, V.;
Asante‐Appiah, E.;
Hwang, P.;
Robertson, M.;
Wahl, J.;
Barr, E.;
Haber, B.

Publication type:

Article

Augmentation of hepatitis C virus-specific immunity and sustained virologic response.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 9, p. 742, doi. 10.1111/jvh.12702

By:

Shrivastava, S.;
Wilson, E.;
Poonia, B.;
Tang, L.;
Osinusi, A.;
Kohli, A.;
Kottilil, S.

Publication type:

Article

Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 9, p. 789, doi. 10.1111/jvh.12703

By:

Young, K.;
Liu, B.;
Bhuket, T.;
Younossi, Z.;
Saab, S.;
Ahmed, A.;
Wong, R. J.

Publication type:

Article

Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 9, p. 750, doi. 10.1111/jvh.12704

By:

Buti, M.;
Domínguez‐Hernández, R.;
Oyagüez, I.;
Casado, M. A.;
Esteban, R.

Publication type:

Article

Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1194, doi. 10.1111/jvh.12750

By:

Cholankeril, G.;
Yoo, E. R.;
Hu, M.;
Gadiparthi, C.;
Khan, M. A.;
Perumpail, R. B.;
Bonham, C. A.;
Ahmed, A.

Publication type:

Article

The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1143, doi. 10.1111/jvh.12751

By:

Li, Q.;
Lu, C.;
Li, W.;
Huang, Y.;
Chen, L.

Publication type:

Article

Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1082, doi. 10.1111/jvh.12720

By:

Shawa, I. T.;
Felmlee, D. J.;
Hegazy, D.;
Sheridan, D. A.;
Cramp, M. E.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1079, doi. 10.1111/jvh.12607
Publication type:: Article

Hepatitis C virus infection and risk of multiple myeloma: Evidence from a meta-analysis based on 17 case-control studies.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1151, doi. 10.1111/jvh.12742

By:

Li, Y.;
Zhang, L.;
Li, W.

Publication type:

Article

Audio-computer-assisted survey interview and patient navigation to increase chronic viral hepatitis diagnosis and linkage to care in urban health clinics.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1184, doi. 10.1111/jvh.12744

By:

Torre, A. N.;
Castaneda, I.;
Ahmad, M.;
Ekholy, N.;
Tham, N.;
Herrera, I. B.;
Beaty, P.;
Malapero, R. J.;
Ayoub, F.;
Slim, J.;
Johnson, M. B.

Publication type:

Article

Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1160, doi. 10.1111/jvh.12745

By:

Teng, W.;
Hsieh, Y.‐C.;
Lui, K.‐W.;
Chen, W.‐T.;
Hung, C.‐F.;
Huang, C.‐H.;
Chen, Y.‐C.;
Jeng, W.‐J.;
Lin, C.‐C.;
Lin, C.‐Y.;
Lin, S.‐M.;
Sheen, I.‐S.

Publication type:

Article

Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1168, doi. 10.1111/jvh.12746

By:

Schiavinato, A.;
Zanetto, A.;
Pantano, G.;
Tosato, F.;
Nabergoj, M.;
Fogar, P.;
Piva, E.;
Gambato, M.;
Franceschet, E.;
Floreani, A.;
Farinati, F.;
Burra, P.;
Russo, F. P.;
Plebani, M.

Publication type:

Article

A comparative study of hepatitis B virus X protein mutants K130M, V131I and KV130/131 MI to investigate their roles in fibrosis, cirrhosis and hepatocellular carcinoma.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1121, doi. 10.1111/jvh.12747

By:

Siddiqui, Z. I.;
Farooqui, S. R.;
Azam, S. A.;
Afroz, M.;
Wajid, S.;
Parveen, S.;
Kazim, S. N.

Publication type:

Article

Estimate of vertical transmission of Hepatitis C virus in Pakistan in 2007 and 2012 birth cohorts.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1177, doi. 10.1111/jvh.12748

By:

Benova, Lenka;
Awad, Susanne Faissal;
Abu‐Raddad, Laith Jamal

Publication type:

Article

Association of single nucleotide polymorphisms in micro RNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: A study in a Saudi Arabian population.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1132, doi. 10.1111/jvh.12749

By:

Al‐Qahtani, A. A.;
Al‐Anazi, M. R.;
Nazir, N.;
Wani, K.;
Abdo, A. A.;
Sanai, F. M.;
Khan, M. Q.;
Al‐Ashgar, H. I.;
Albenmousa, A.;
Al‐hamoudi, W. K.;
Alswat, K. A.;
Al‐Ahdal, M. N.

Publication type:

Article

The impact of smoking on incident type 2 diabetes in a cohort with hepatitis B but not hepatitis C infection.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1114, doi. 10.1111/j.1365-2893.2010.01337.x

By:

Wang, C.‐S.;
Chang, T.‐T.;
Yao, W.‐J.;
Wang, S.‐T.;
Chou, P.

Publication type:

Article

Cover Image.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. i, doi. 10.1111/jvh.12594

By:

Siddiqui, Z. I.;
Farooqui, S. R.;
Azam, S. A.;
Afroz, M.;
Wajid, S.;
Parveen, S.;
Kazim, S. N.

Publication type:

Article

Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1089, doi. 10.1111/jvh.12736

By:

Wong, R. J.;
Nguyen, M. T.;
Trinh, H. N.;
Chan, C.;
Huynh, A.;
Ly, M. T.;
Nguyen, H. A.;
Nguyen, K. K.;
Torres, S.;
Yang, J.;
Liu, B.;
Garcia, R. T.;
Bhuket, T.;
Baden, R.;
Levitt, B.;
Silveira, E.;
Gish, R. G.

Publication type:

Article

Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1098, doi. 10.1111/jvh.12737

By:

Kawagishi, N.;
Suda, G.;
Onozawa, M.;
Kimura, M.;
Maehara, O.;
Ohara, M.;
Izumi, T.;
Umemura, M.;
Ito, J.;
Nakai, M.;
Sho, T.;
Natsuizaka, M.;
Morikawa, K.;
Ogawa, K.;
Sakamoto, N.

Publication type:

Article

HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1107, doi. 10.1111/jvh.12738

By:

Stelma, F.;
van der Ree, M. H.;
Jansen, L.;
Peters, M. W.;
Janssen, H. L. A.;
Zaaijer, H. L.;
Takkenberg, R. Bart;
Reesink, H. W.

Publication type:

Article

Long-term follow-up of patients triply infected with HIV and hepatitis B and C viruses in a comprehensive hospital in central China.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 12, p. 1192, doi. 10.1111/jvh.12739

By:

Yang, R.;
Gui, X.;
Xiong, Y.;
Gao, S.

Publication type:

Article

Historical epidemiology of hepatitis C virus in select countries—volume 4.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 8, doi. 10.1111/jvh.12762

By:

Maaroufi, A.;
Vince, A.;
Himatt, S. M.;
Mohamed, R.;
Fung, J.;
Opare-Sem, O.;
Workneh, A.;
Njouom, R.;
Al ghazzawi, I.;
Abdulla, M.;
Kaliaskarova, K. S.;
Owusu-Ofori, S.;
Abdelmageed, M. K.;
Adda, D.;
Akin, O.;
Al Baqali, A.;
Al Dweik, N.;
Al Ejji, K.;
Al Kaabi, S.;
Al Naamani, K.

Publication type:

Article

Strategies to manage hepatitis C virus infection disease burden—Volume 4.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 44, doi. 10.1111/jvh.12759

By:

Chen, D. S.;
Hamoudi, W.;
Mustapha, B.;
Layden, J.;
Nersesov, A.;
Reic, T.;
Garcia, V.;
Rios, C.;
Mateva, L.;
Njoya, O.;
Al-Busafi, S. A.;
Abdelmageed, M. K.;
Abdulla, M.;
Adda, D.;
Akin, O.;
Al Baqali, A.;
Al Dweik, N.;
Al Ejji, K.;
Al ghazzawi, I.;
Al Kaabi, S.

Publication type:

Article

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 25, doi. 10.1111/jvh.12760

By:

Chan, H. L. Y.;
Chen, C. J.;
Omede, O.;
Al Qamish, J.;
Al Naamani, K.;
Bane, A.;
Tan, S. S.;
Simonova, M.;
Cardenas, I.;
Derbala, M.;
Akin, O.;
Phillips, R. O.;
Abdelmageed, M. K.;
Abdulla, M.;
Adda, D.;
Al Baqali, A.;
Al Dweik, N.;
Al Ejji, K.;
Al ghazzawi, I.;
Al Kaabi, S.

Publication type:

Article

Comparison of 208-week sequential therapy with telbivudine and entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg- IFNα-2a therapy: An open-labelled, randomized, controlled, 'real-life' trial.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 36, doi. 10.1111/jvh.12790

By:

Luo, X. D.;
Chen, X. F.;
Zhou, Y.;
Chen, X. P.

Publication type:

Article

Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 66, doi. 10.1111/jvh.12791

By:

Huang, D.;
Sansas, B.;
Jiang, J. H.;
Gong, Q. M.;
Jin, G. D.;
Calais, V.;
Yu, D. M.;
Zhu, M. Y.;
Wei, D.;
Zhang, D. H.;
Inchauspé, G.;
Zhang, X. X.;
Zhu, R.

Publication type:

Article

Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 21, doi. 10.1111/jvh.12792

By:

Wang, M.‐L.;
Chen, E.‐Q.;
Zhang, D.‐M.;
Du, L.‐Y.;
Yan, L.‐B.;
Zhou, T.‐Y.;
Lei, X.‐Z.;
Lei, B.‐J.;
Lu, J.‐J.;
Liao, J.;
Tang, H.

Publication type:

Article

The experience of management of chronic hepatitis B in China.

Published in:

2017

By:

Ren, H.

Publication type:

Editorial

Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 29, doi. 10.1111/jvh.12794

By:

Pan, H.‐Y.;
Song, W.‐Y.;
Zheng, W.;
Tong, Y.‐X.;
Yang, D.‐H.;
Dai, Y.‐N.;
Chen, M.‐J.;
Wang, M.‐S.;
Huang, Y.‐C.;
Zhang, J.‐J.;
Huang, H.‐J.

Publication type:

Article

Editorial for 'Supplement on Optimal Therapy for Chronic Hepatitis B in China'.

Published in:

2017

By:

Foster, Graham

Publication type:

Editorial

Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 57, doi. 10.1111/jvh.12786

By:

Cao, Z.;
Li, Z.;
Wang, Y.;
Liu, Y.;
Mo, R.;
Ren, P.;
Chen, L.;
Lu, J.;
Li, H.;
Zhuang, Y.;
Wang, X.;
Zhao, G.;
Tang, W.;
Xiang, X.;
Wang, H.;
Cai, W.;
Liu, L.;
Zhu, C.;
Bao, S.;
Xie, Q.

Publication type:

Article

Safety and efficacy of telbivudine for chronic hepatitis B during the entire pregnancy: Long-term follow-up.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 43, doi. 10.1111/jvh.12785

By:

Shang, J.;
Wen, Q.;
Wang, C. C.;
Liu, K.;
Bai, L.;
Tang, H.

Publication type:

Article

Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 6, doi. 10.1111/jvh.12787

By:

Liu, J.;
Chen, T.;
Zhao, Y.

Publication type:

Article

Prospective cohort study on the efficacy and safety of telbivudine used throughout pregnancy in blocking mother-to-child transmission of hepatitis B virus.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 49, doi. 10.1111/jvh.12788

By:

Yi, W.;
Li, M.‐H.;
Xie, Y.;
Wu, J.;
Hu, Y.‐H.;
Zhang, D.;
Zhang, Y.;
Cao, W.‐H.

Publication type:

Article

Improvement of telbivudine on renal function and massive proteinuria: A case report.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 75, doi. 10.1111/jvh.12789

By:

Liu, J.;
Yao, N.;
Zhao, Y.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2017, v. 24, p. 1, doi. 10.1111/jvh.12806
Publication type:: Article

Peginterferon is preferable to entecavir for prevention of unfavourable events in patients with HBeAg-positive chronic hepatitis B: A five-year observational cohort study.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, p. 12, doi. 10.1111/jvh.12755

By:

Li, S.‐Y.;
Li, H.;
Xiong, Y.‐L.;
Liu, F.;
Peng, M.‐L.;
Zhang, D.‐Z.;
Ren, H.;
Hu, P.

Publication type:

Article

Interferon-free therapies for patients with chronic hepatitis C genotype 3 infection: A systematic review.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 904, doi. 10.1111/jvh.12660

By:

Gimeno‐Ballester, V.;
Buti, M.;
San Miguel, R.;
Riveiro, M.;
Esteban, R.

Publication type:

Article

Risk factors for vertical transmission of hepatitis E virus infection.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 1067, doi. 10.1111/jvh.12730

By:

Sharma, S.;
Kumar, A.;
Kar, P.;
Agarwal, S.;
Ramji, S.;
Husain, S. A.;
Prasad, S.

Publication type:

Article

Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 1032, doi. 10.1111/jvh.12732

By:

Lok, A. S.;
Ganova‐Raeva, L.;
Cloonan, Y.;
Punkova, L.;
Lin, H.‐H. S.;
Lee, W. M.;
Ghany, M. G.;
Lau, Daryl T‐Y;
Chung, Raymond T.;
Roberts, Lewis R.;
Smith, Coleman I.;
Di Bisceglie, Adrian M.;
‐Melman, Mauricio;
Janssen, L. A.;
Wong, David K.;
Juan, Joshua;
Feld, Jordan;
Yim, Colina;
Heathcote, Jenny;
Perrillo, Robert

Publication type:

Article

Implications of HCV RNA level at week 4 of direct antiviral treatments for hepatitis C.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 966, doi. 10.1111/jvh.12731

By:

Johnson, K.;
Green, P. K.;
Ioannou, G. N.

Publication type:

Article

Prevalence of chronic kidney disease in patients with chronic hepatitis B: A cross-sectional survey.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 1043, doi. 10.1111/jvh.12733

By:

Ning, L.;
Lin, W.;
Hu, X.;
Fan, R.;
Liang, X.;
Wu, Y.;
Shen, S.;
Yu, R.;
Sun, J.;
Hou, J.

Publication type:

Article

Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 1052, doi. 10.1111/jvh.12735

By:

Kim, H. S.;
Rotundo, L.;
Yang, J. D.;
Kim, D.;
Kothari, N.;
Feurdean, M.;
Ruhl, C.;
Unalp‐arida, A.

Publication type:

Article

Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta-analysis.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 936, doi. 10.1111/jvh.12722

By:

Wedemeyer, H.;
Craxí, A.;
Zuckerman, E.;
Dieterich, D.;
Flisiak, R.;
Roberts, S. K.;
Pangerl, A.;
Zhang, Z.;
Martinez, M.;
Bao, Y.;
Calleja, J.‐L.

Publication type:

Article

Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experience.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 927, doi. 10.1111/jvh.12721

By:

Hlaing, N. K. T.;
Mitrani, R. A.;
Aung, S. T.;
Phyo, W. W.;
Serper, M.;
Kyaw, A. M. M.;
Bwa, A. H.;
Win, K. M.;
Reddy, K. R.

Publication type:

Article

Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 990, doi. 10.1111/jvh.12723

By:

Kim, G.‐A.;
Han, S.;
Kim, H.‐D.;
An, J.;
Lim, Y.‐S.

Publication type:

Article

Limited impact of awareness-raising campaigns on hepatitis C testing practices among general practitioners.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 944, doi. 10.1111/jvh.12724

By:

McLeod, A.;
Cullen, B. L.;
Hutchinson, S. J.;
Roy, K. M.;
Dillon, J. F.;
Stewart, E. A.;
Goldberg, D. J.

Publication type:

Article

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 976, doi. 10.1111/jvh.12726

By:

Bielen, R.;
Moreno, C.;
Van Vlierberghe, H.;
Bourgeois, S.;
Mulkay, J.‐P.;
Vanwolleghem, T.;
Verlinden, W.;
Brixco, C.;
Decaestecker, J.;
Galocsy, C.;
Janssens, F.;
Van Overbeke, L.;
Van Steenkiste, C.;
D'Heygere, F.;
Cool, M.;
Wuyckens, K.;
Nevens, F.;
Robaeys, G.

Publication type:

Article

HIV/ HCV coinfection and the risk of cardiovascular disease: A meta-analysis.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 11, p. 998, doi. 10.1111/jvh.12725

By:

Osibogun, O.;
Ogunmoroti, O.;
Michos, E. D.;
Spatz, E. S.;
Olubajo, B.;
Nasir, K.;
Madhivanan, P.;
Maziak, W.

Publication type:

Article